“…During the period studied, the mean cost per patient increased from 6,634 to 9,474 Euros. Multivariate analysis shows that from 2001 to 2008 the incidence of THA hospitalizations has significantly increased for both sexes and only men showed a significant reduction in IHM after THA. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The total costs attributable to excess hospital stays for MRSA and G3CREC BSIs were 44.0 and 18.1 million Euros (63.1 and 29.7 million international dollars), respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CAM was frequently used by parents over 30 years (33%), female parents (32%), highly educated parents (35%), and parents with high monthly net income (3000-3999 euros, 34%). The users of CAM had more negative attitudes towards medicines than non-users of CAM. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The pharmaco-economic evaluation shows that this modest effectiveness drives the costs per QALY and the costs per year free of end-organ damage to millions of euros. Differentiation of patients who may benefit from ERT should be improved to enhance cost-effectiveness.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…For all types of costs, the percentage of patients using health care resources varied significantly according to the level of asthma control. The average cost (euros/3-months/patient) of controlled asthma was €85.4 (SD: 153.5) in France compared with €314.0 (SD: 2,160.4) for partially controlled asthma and €537.9 (SD: 2,355.7) for uncontrolled asthma (p<0.0001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cost of screening was yearly about 5000 euros (250 children screened every year).…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In a meta-analysis of two studies (2689 patients) with minimal heterogeneity and high-quality evidence, nurse practitioner care resulted in lower mean health services costs per consultation (mean difference: −€6.41; 95% CI −€9.28 to −€3.55; p<0.0001) (2006 euros). In two trials of alternative provider specialised ambulatory care roles, nurse practitioners were equivalent to physicians in all but three patient outcomes and one health system outcome favouring nurse practitioner care. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, our analysis revealed that rituximab therapy is significantly more cost-effective than both abatacept and TNFi over a willingness-to-pay range of 0 to 80,000 euros. CONCLUSIONS: All three treatment options were similarly effective; however, when costs were factored into the treatment decision, rituximab was the best option available to patients whose first TNFi treatment failed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Costs, estimated from perspective of the Spanish Public Healthcare System (Euros 2014), included insulin treatment and non-severe hypoglycemia management costs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Self-reported clinical data from DESIR and French public data were used to value health resource utilisation and productivity losses in 2013 Euros. Factors associated with costs, including and excluding biological drugs, were identified in generalised linear models using the generalised estimating equations algorithm to account for repeated observations over participants. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Reasons for hospitalization, type of admission (emergency or otherwise), length of stay, rehabilitation transfers, and death at discharge were identified and costs of acute and rehabilitation care determined (2012 Euros). In total, 533 044 AF patients (mean age ± SD 78.0 ± 11.4 years, 47.1% women) were hospitalized in 2012 for any reason. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: The IMS CORE Diabetes Model was used to project clinical outcomes and costs, expressed in 2015 Euros, over patient lifetimes. Baseline cohort data and treatment effects were taken from the 26-week, open-label LIRA-LIXI™ trial (NCT01973231). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All costs are presented in 2015 HUF / Euros (€). RESULTS: 156 children with varicella were included (75 outpatients, 81 inpatients), with a mean age of 4.4 (SD: 2.0) and 3.7 (SD: 2.1) years, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Higher lifetime costs for SAP with automated insulin suspension resulted in projected incremental cost-effectiveness ratios for the SAP with automated insulin suspension versus CSII of Swedish Krona (SEK) 139,795 [euros (EUR) 14,648] per QALY gained for patients at increased risk for hypoglycemia and SEK 251,896 (EUR 26,395) per QALY gained for patients with uncontrolled HbA1c. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Costs were expressed in 2013 euros. RESULTS: A total of 14,782 patients were treated for knee osteoarthritis (67% women; mean age = 68 years). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Total quality-adjusted life-years and costs in 2017 euros were calculated over a 5-year (lifetime) time horizon. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Medication and exacerbation management costs in euros were estimated from Spanish public sources for 2016. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All costs were converted to euros based on the 2013 currency rate. RESULTS: In total 7044 patients were included (44% with TBI, 13% with ICH, 27% with SAH, 16% with AIS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The Spanish NHS perspective was adopted, taking into account exclusively direct health costs from 2017 expressed in Euros. Drug prices used were the reported ex-factory prices. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Costs were evaluated from a National Health Service perspective for France, Germany, and Spain, and in a pooled analysis, and were expressed in 2015 Euros (EUR). Quality of life was assessed using the 15D health-related quality-of-life instrument and mapped to utility scores. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso